MCCLURG RONALD W. (Chief Financial Officer) purchased 186.7% of their position (28K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market purchase worth $25.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/24/2022ACC: 0001837830-22-000002
Officer· Chief Financial Officer
Since Jan 2021
+28K
Net shares
Net buyer
$25.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
28K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17.50K
Price / share
$0.85
Trade value
$14.92K
% of position
116.7%
5/20/2022
15K→32.50K
Common Stock
Direct
Shares
+10.50K
Price / share
$0.98
Trade value
$10.29K
% of position
32.3%
5/24/2022
32.50K→43K
Total
Net shares
+28K
Net value
$25.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/20/2022 | P · Purchase | +17.50K | $0.85 | $14.92K | 116.7% | 15K | 32.50K |
| Common Stock Direct | 5/24/2022 | P · Purchase | +10.50K | $0.98 | $10.29K | 32.3% | 32.50K | 43K |
| Total | +28K | $25.22K | ||||||
Derivative Transactions0
No derivative transactions reported